Etiket: Biomed
Hot Stocks today: Strong half year for the markets – Mainz Biomed obtains liquidity
PCR test ColoAlert is to be approved in the USA. On the finanzen.net podcast, Hot Bets, we are talking about the first half of the year, among other things. For…
Mainz Biomed share: The history of Mainz Biomed – detecting cancer earlier with better diagnostics
shares in this article indexes in this article • Mainz Biomed was formed in 2021 to acquire PharmGenomics and commercialize its product portfolio • The main product is currently ColoAlert:…